FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jun 2021
Historique:
received: 10 05 2021
revised: 07 06 2021
accepted: 11 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 20 7 2021
Statut: epublish

Résumé

FcRn plays a major role in regulating immune homeostasis, but it is also able to transport biologics across cellular barriers. The question of whether FcRn could be an efficient transporter of biologics across the nasal epithelial barrier is of particular interest, as it would allow a less invasive strategy for the administration of biologics in comparison to subcutaneous, intramuscular or intravenous administrations, which are often used in clinical practice. A focused systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. It was registered on the international prospective register of systematic reviews PROSPERO, which helped in identifying articles that met the inclusion criteria. Clinical and preclinical studies involving FcRn and the nasal delivery of biologics were screened, and the risk of bias was assessed across studies using the Oral Health Assessment Tool (OHAT). Among the 12 studies finally included in this systematic review (out of the 758 studies screened), 11 demonstrated efficient transcytosis of biologics through the nasal epithelium. Only three studies evaluated the potential toxicity of biologics' intranasal delivery, and they all showed that it was safe. This systematic review confirmed that FcRn is expressed in the nasal airway and the olfactory epithelium, and that FcRn may play a role in IgG and/or IgG-derived molecule-transcytosis across the airway epithelium. However, additional research is needed to better characterize the pharmacokinetic and pharmacodynamic properties of biologics after their intranasal delivery.

Identifiants

pubmed: 34204226
pii: ijms22126475
doi: 10.3390/ijms22126475
pmc: PMC8234196
pii:
doi:

Substances chimiques

Biological Products 0
Biomarkers 0
Histocompatibility Antigens Class I 0
Receptors, Fc 0
Fc receptor, neonatal TW3XAW0RCY

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Commun. 2019 Nov 6;10(1):5031
pubmed: 31695028
Handb Exp Pharmacol. 2008;(181):3-18
pubmed: 18071939
J Cell Sci. 2000 Apr;113 ( Pt 7):1277-85
pubmed: 10704378
Hum Reprod. 2005 Jul;20(7):1805-13
pubmed: 15817590
Biochim Biophys Acta. 2009 Apr;1788(4):892-910
pubmed: 18983815
MAbs. 2014;6(5):1229-42
pubmed: 25517308
Biochem J. 1980 Apr 15;188(1):9-16
pubmed: 7406892
J Immunol. 2008 Apr 15;180(8):5548-57
pubmed: 18390739
MAbs. 2016 Aug-Sep;8(6):1064-78
pubmed: 27232760
Pharmaceutics. 2018 Jul 26;10(3):
pubmed: 30050027
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9763-8
pubmed: 15210944
J Control Release. 2018 Sep 28;286:467-484
pubmed: 30081144
Clin Otolaryngol Allied Sci. 1999 Feb;24(1):67-8
pubmed: 10196653
Nature. 1975 Aug 7;256(5517):495-7
pubmed: 1172191
J Aerosol Med. 2005 Fall;18(3):294-303
pubmed: 16181004
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):E2018-27
pubmed: 22733753
Eur J Pharm Sci. 2016 Jan 1;81:52-9
pubmed: 26435216
Mol Cell. 2001 Apr;7(4):867-77
pubmed: 11336709
Sci Rep. 2018 Oct 2;8(1):14648
pubmed: 30279529
J Pharm Sci. 2008 Mar;97(3):1165-78
pubmed: 17628494
Eur Respir J. 2000 Feb;15(2):367-72
pubmed: 10706506
Nat Rev Drug Discov. 2018 Mar;17(3):197-223
pubmed: 29192287
Expert Opin Drug Deliv. 2015 Jun;12(6):1027-39
pubmed: 25557066
Antibodies (Basel). 2019 Apr 25;8(2):
pubmed: 31544836
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5084-9
pubmed: 16549777
Nature. 1989 Jan 12;337(6203):184-7
pubmed: 2911353
Nat Biotechnol. 2010 Nov;28(11):1203-7
pubmed: 20953198
J Virol. 2011 Oct;85(20):10542-53
pubmed: 21849464
MAbs. 2014 Jul-Aug;6(4):928-42
pubmed: 24802048
Protoplasma. 2016 Nov;253(6):1557-1564
pubmed: 26634928
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Nat Rev Immunol. 2007 Sep;7(9):715-25
pubmed: 17703228
Neuropsychopharmacology. 2007 Jan;32(1):239-43
pubmed: 16936707
Pharmacol Ther. 2016 May;161:22-39
pubmed: 27016466
Ciba Found Symp. 1982;(92):209-32
pubmed: 6295720
J Control Release. 2016 Jul 28;234:21-32
pubmed: 27173943
Glia. 2011 May;59(5):750-70
pubmed: 21360755
MAbs. 2019 Feb/Mar;11(2):350-372
pubmed: 30466347
Adv Drug Deliv Rev. 2015 Aug 30;91:109-24
pubmed: 25703189
Infect Immun. 2015 Jan;83(1):77-89
pubmed: 25312957
Am J Rhinol. 2007 Jan-Feb;21(1):110-6
pubmed: 17283572
Mol Biol Cell. 2012 Jul;23(13):2537-45
pubmed: 22573886
J Clin Invest. 2006 Aug;116(8):2142-2151
pubmed: 16841095
Immunol Today. 1997 Dec;18(12):592-8
pubmed: 9425738
Physiology (Bethesda). 2013 Nov;28(6):391-403
pubmed: 24186934
J Immunol. 2009 Jun 15;182(12):7663-71
pubmed: 19494290
Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5
pubmed: 20849944
Eur J Immunol. 1985 Jul;15(7):733-8
pubmed: 2988974
Int J Mol Sci. 2019 Mar 19;20(6):
pubmed: 30893823
Neuroendocrinology. 2013;97(2):176-82
pubmed: 22922661
J Comp Neurol. 1986 Sep 8;251(2):260-80
pubmed: 3782501
Mol Biol Cell. 2004 Apr;15(4):1746-59
pubmed: 14767057
Nat Rev Drug Discov. 2003 Jan;2(1):52-62
pubmed: 12509759
Pharm Res. 1997 May;14(5):631-7
pubmed: 9165535
Int Immunol. 2001 Aug;13(8):993-1002
pubmed: 11470769
Hum Immunol. 2011 Dec;72(12):1176-87
pubmed: 21978715
Diabetes. 2014 Dec;63(12):4083-8
pubmed: 25028522
Adv Immunol. 2009;103:77-115
pubmed: 19755184
Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1106-18
pubmed: 16997417
Mol Immunol. 2011 Mar;48(6-7):860-6
pubmed: 21256596
Toxicol Pathol. 2016 Apr;44(3):486-91
pubmed: 26516163
J Clin Invest. 1999 Oct;104(7):903-11
pubmed: 10510331
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
BMC Vet Res. 2016 Oct 20;12(1):237
pubmed: 27765059
J Clin Immunol. 2013 Jan;33 Suppl 1:S9-17
pubmed: 22948741
Annu Rev Psychol. 2019 Jan 4;70:747-770
pubmed: 30089228
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18709-14
pubmed: 17116867
J Clin Epidemiol. 2012 Feb;65(2):163-78
pubmed: 21959223
PLoS One. 2013;8(1):e53783
pubmed: 23326505
J Pharm Sci. 2015 Feb;104(2):368-77
pubmed: 25175600
Sci Transl Med. 2013 Nov 27;5(213):213ra167
pubmed: 24285486
Drug Metab Dispos. 2014 Nov;42(11):1867-72
pubmed: 25024401
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
J Diabetes Sci Technol. 2011 Jan 01;5(1):113-9
pubmed: 21303633
Nature. 2014 Oct 30;514(7524):642-5
pubmed: 25119033
Int J Pharm. 2017 Oct 30;532(1):537-546
pubmed: 28917988
Mol Immunol. 2013 Dec;56(4):660-74
pubmed: 23917469
Biomolecules. 2018 Oct 15;8(4):
pubmed: 30326650
BioDrugs. 2014 Apr;28(2):171-80
pubmed: 24150980
Int Immunol. 2001 Dec;13(12):1551-9
pubmed: 11717196
J Control Release. 2004 Mar 24;95(3):489-500
pubmed: 15023460
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Neuron. 2015 Oct 21;88(2):289-97
pubmed: 26494278
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4388-93
pubmed: 21368166
J Exp Med. 2002 Aug 5;196(3):303-10
pubmed: 12163559
Adv Drug Deliv Rev. 2012 May 15;64(7):614-28
pubmed: 22119441
J Control Release. 2014 Dec 28;196:344-54
pubmed: 25451545
Mol Immunol. 2015 Oct;67(2 Pt A):131-41
pubmed: 25766596
Pharm Res. 2016 Jun;33(6):1337-50
pubmed: 26887679
Eur J Pharm Biopharm. 2008 Aug;69(3):793-807
pubmed: 18477504
J Exp Med. 2003 Feb 3;197(3):315-22
pubmed: 12566415
Mol Immunol. 2009 May;46(8-9):1878-82
pubmed: 19269032
Pharm Res. 2015 Feb;32(2):665-79
pubmed: 25145337
Pharmaceutics. 2019 Aug 01;11(8):
pubmed: 31374872
Proc Natl Acad Sci U S A. 1996 May 28;93(11):5512-6
pubmed: 8643606
Nat Biotechnol. 2011 Feb;29(2):158-63
pubmed: 21240266
Immunology. 2005 Apr;114(4):542-53
pubmed: 15804291
Psychoneuroendocrinology. 2004 Nov;29(10):1326-34
pubmed: 15288712
J Biol Chem. 2014 May 9;289(19):13492-502
pubmed: 24652290
J Biol Chem. 2014 Mar 14;289(11):7812-24
pubmed: 24469444
MAbs. 2014;6(6):1638-48
pubmed: 25484066
Methods Mol Biol. 2016;1438:103-14
pubmed: 27150086
Pharm Res. 2019 Feb 5;36(3):47
pubmed: 30721414
Eur J Immunol. 2006 Nov;36(11):3044-51
pubmed: 17048273
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):255-63
pubmed: 25084017
Sci Transl Med. 2020 Oct 14;12(565):
pubmed: 33055243
N Engl J Med. 2008 Jan 17;358(3):304-5
pubmed: 18199871
MAbs. 2020 Jan-Dec;12(1):1829337
pubmed: 33079615
Clin Pharmacol Ther. 2008 Nov;84(5):548-58
pubmed: 18784655
Eur J Pharm Biopharm. 2012 Feb;80(2):465-9
pubmed: 22120685
J Cereb Blood Flow Metab. 2015 Mar;35(3):371-81
pubmed: 25492117
Springer Semin Immunopathol. 2006 Dec;28(4):397-403
pubmed: 17051393
J Pharm Sci. 2004 Nov;93(11):2645-68
pubmed: 15389672
J Cell Biol. 1984 Jul;99(1 Pt 2):159s-164s
pubmed: 6235233

Auteurs

Maxime Fieux (M)

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'ORL, D'otoneurochirurgie et de Chirurgie Cervico-Faciale, Pierre Bénite, CEDEX, F-69495 Lyon, France.
Université de Lyon, Université Lyon 1, F-69003 Lyon, France.
Univ Paris Est Creteil, INSERM, IMRB, F-94010 Créteil, France.
CNRS ERL 7000, F-94010 Créteil, France.

Sandra Le Quellec (S)

Université de Lyon, Université Lyon 1, F-69003 Lyon, France.
Hospices Civils de Lyon, Hôpital Cardiologique Louis Pradel, Unité D'hémostase Clinique, CEDEX, F-69500 Bron, France.
EA 4609 Hémostase et Cancer, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Hospices Civils de Lyon, Centre de Biologie et de Pathologie Est, Service D'hématologie Biologique, CEDEX, F-69500 Bron, France.

Sophie Bartier (S)

Univ Paris Est Creteil, INSERM, IMRB, F-94010 Créteil, France.
CNRS ERL 7000, F-94010 Créteil, France.
Service d'ORL, de Chirurgie Cervico Faciale, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris, F-94000 Créteil, France.

André Coste (A)

Univ Paris Est Creteil, INSERM, IMRB, F-94010 Créteil, France.
CNRS ERL 7000, F-94010 Créteil, France.
Service d'ORL, de Chirurgie Cervico Faciale, Centre Hospitalier Intercommunal de Créteil, F-94010 Créteil, France.

Bruno Louis (B)

Univ Paris Est Creteil, INSERM, IMRB, F-94010 Créteil, France.
CNRS ERL 7000, F-94010 Créteil, France.

Caroline Giroudon (C)

Hospices Civils de Lyon, Service de la Documentation Centrale, CEDEX, F-69424 Lyon, France.

Mikail Nourredine (M)

Université de Lyon, Université Lyon 1, F-69003 Lyon, France.
Hospices Civils de Lyon, Service de Biostatistique et Bioinformatique, F-69003 Lyon, France.
CNRS, Laboratoire de Biométrie et Biologie Évolutive UMR 5558, F-69100 Villeurbanne, France.

Emilie Bequignon (E)

Univ Paris Est Creteil, INSERM, IMRB, F-94010 Créteil, France.
CNRS ERL 7000, F-94010 Créteil, France.
Service d'ORL, de Chirurgie Cervico Faciale, Centre Hospitalier Intercommunal de Créteil, F-94010 Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH